Back to search
FDAFDA · Food and drugs·Recall number D-1088-2014

Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only. Physician sample in clamshell container with seven heat-sealed sachets. Rx Only. Watson Pharmaceuticals Inc, Corona, CA, 92890. NDC: 52544-084-77.

Published March 5, 2014 · Recall initiated: February 7, 2014

Summary

FDA records drug Class III recall D-1088-2014, published March 5, 2014 and initiated February 7, 2014. Recalling firm: Actavis; Status: Terminated; Reported quantity: 38,227 Clamshells; Lot: Lot #: 514656; Expiry: 03/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Drug potency was compromised during shipment.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis
Distributor
Distributed nationwide to physicians as samples. No military/ govt/ VA or foreign consignees.
Lot
Lot #: 514656; Expiry: 03/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only. Physician sample in clamshell container with seven heat-sealed sachets. Rx Only. Watson Pharmaceuticals Inc, Corona, CA, 92890. NDC: 52544-084-77. recalled?

Yes. FDA published recall D-1088-2014 on March 5, 2014. Reported hazard: Subpotent Drug: Drug potency was compromised during shipment.

What should I do if I have this product?

Voluntary: Firm initiated · Letter